BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 25496209)

  • 1. Adverse drug events identified by triggers at a teaching hospital in Brazil.
    Giordani F; Rozenfeld S; Martins M
    BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
    Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
    Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a trigger tool based on global trigger tools to identify adverse drug events in obstetric inpatients in China.
    Wu S; Yin Q; Wu L; Wu Y; Yu N; Yan J; Bian Y
    BMC Health Serv Res; 2024 Jan; 24(1):72. PubMed ID: 38225629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug events in critically ill patients with cancer: incidence, characteristics, and outcomes.
    Nazer LH; Hawari F; Al-Najjar T
    J Pharm Pract; 2014 Apr; 27(2):208-13. PubMed ID: 24319079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study.
    Aljadhey H; Mahmoud MA; Ahmed Y; Sultana R; Zouein S; Alshanawani S; Mayet A; Alshaikh MK; Kalagi N; Al Tawil E; El Kinge AR; Arwadi A; Alyahya M; Murray MD; Bates D
    BMJ Open; 2016 Jul; 6(7):e010831. PubMed ID: 27406640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study.
    Eshetie TC; Hailemeskel B; Mekonnen N; Paulos G; Mekonnen AB; Girma T
    BMC Pediatr; 2015 Jul; 15():83. PubMed ID: 26173560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized surveillance of adverse drug events in hospital patients.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    JAMA; 1991 Nov; 266(20):2847-51. PubMed ID: 1942452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics associated with the occurrence of adverse events: a retrospective medical record review using the Global Trigger Tool in a fully digitalized tertiary teaching hospital in Korea.
    Hwang JI; Chin HJ; Chang YS
    J Eval Clin Pract; 2014 Feb; 20(1):27-35. PubMed ID: 23890097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug events in adult patients leading to emergency department visits.
    Sikdar KC; Alaghehbandan R; MacDonald D; Barrett B; Collins KD; Donnan J; Gadag V
    Ann Pharmacother; 2010 Apr; 44(4):641-9. PubMed ID: 20233911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants.
    Zaidenstein R; Eyal S; Efrati S; Akivison L; Michowitz MK; Nagornov V; Golik A
    Pharmacoepidemiol Drug Saf; 2002; 11(3):235-8. PubMed ID: 12051123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study.
    Sakuma M; Ida H; Nakamura T; Ohta Y; Yamamoto K; Seki S; Hiroi K; Kikuchi K; Nakayama K; Bates DW; Morimoto T
    BMJ Qual Saf; 2014 Oct; 23(10):830-7. PubMed ID: 24742779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
    Eguale T; Buckeridge DL; Verma A; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    JAMA Intern Med; 2016 Jan; 176(1):55-63. PubMed ID: 26523731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study.
    Ersulo TA; Yizengaw MA; Tesfaye BT
    BMC Pharmacol Toxicol; 2022 May; 23(1):30. PubMed ID: 35581618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Medication-Related Adverse Drug Events in Nursing Facilities in East Texas.
    Tenhunen ML; Smithers B; Tucker B
    Consult Pharm; 2016; 31(8):436-9. PubMed ID: 27535078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital admissions caused by adverse drug events: an Australian prospective study.
    Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
    Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
    Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
    JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.